Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04547881 · ClinicalTrials.gov registry record
Gravity Assisted Technique for Esophageal Endoscopic Submucosal Dissection (ESD)
A clinical trial, sponsored by Baylor College of Medicine.
- Completed
- Registry status
- 32
- Enrollment target
NCT04547881: Completed study, sponsored by Baylor College of Medicine.
NCT04547881 is a clinical trial that has completed, run by Baylor College of Medicine. The registered enrollment target is 32 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04547881 has completed, sponsored by Baylor College of Medicine.
- COMPLETED
- Registry status
- 32 participants
- Enrollment target
Study Summary
This is a prospective data recording study, all patients will receive standard medical care and no experimental interventions will be performed. All patients scheduled to undergo esophageal ESD from December 2018 to December 2021 as medically indicated will be considered for the study, Patients in whom esophageal ESD is considered as part of their standard medical care will be offered to participate in this study. The principle investigator who performing the procedure will also discuss the study with the subjects and ask them to sign a consent. If the patient agrees to participate, he/she will be given the informed consent form and allowed enough time to read it. Then if the patient agrees, he/she will sign the consent form. Data will be prospectively recorded according to the data collection form.
Primary Outcome
To assess the mean time needed to perform esophageal ESD using this technique.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2016-12-12 |
| Est. Completion | 2022-02-04 |
What the finished NCT04547881 record still lists
NCT04547881 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 32 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT04547881 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04547881 about?
NCT04547881 is a clinical study titled "Gravity Assisted Technique for Esophageal Endoscopic Submucosal Dissection (ESD)". This is a prospective data recording study, all patients will receive standard medical care and no experimental interventions will be performed. All patients scheduled to undergo esophageal ESD from December 2018 to December 2021 as medically indicated will be considered for the study, Patients in w...
What is the current status of trial NCT04547881?
This trial is currently completed. The enrollment target is 32 participants. The study started on 2016-12-12. Estimated completion is 2022-02-04.
Who is sponsoring clinical trial NCT04547881?
This trial is sponsored by Baylor College of Medicine, which has 616 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02445781 · 32 participants · Early Phase 1
Differing Levels of Hypoglycemia
- NCT02792270 · 32 participants · NA
Caloric Restriction In Sarcoma Patients Treated With Pre-Operative RT
- NCT03068910 · 32 participants · Early Phase 1
Hyperandrogenemia and Altered Day-night LH Pulse Patterns
- NCT03208868 · 32 participants · NA
Leucine Enriched Essential Amino Acid Mixture to Reverse Muscle Loss in Cirrhosis
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI